Comparative Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of Influenza

Summary

The purpose of this study is: * to assess the efficacy of Ergoferon in treatment of influenza; * to assess the safety of Ergoferon in treatment of influenza; * to compare the efficacy of Ergoferon and Oseltamivir for treatment of influenza.

Timeline

Start

2015-02-20

Primary completion

2018-04-16

Completion

2018-04-16

Outcome

Met primary endpoint

registry analysis (non-inferiority test); Ergoferon (1 Tablet 3 Times a Day) vs Oseltamivir (Tamiflu) - 1 Capsule (75mg) Two Times a Day; p <0.0001; Z-value 8.56 NCT01850446 ↗

Drugs

Indications